跳至主要内容
临床试验/CTRI/2023/11/060353
CTRI/2023/11/060353
尚未招募
3 期

A Randomized controlled study comparing Nutraceuticals and Pregabalin in Diabetic Neuropathy - NI

ARNE KRISHNA GEETHA0 个研究点目标入组 0 人待定

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
Health Condition 1: E134- Other specified diabetes mellituswith neurological complications
发起方
ARNE KRISHNA GEETHA
状态
尚未招募
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Interventional

研究者

发起方
ARNE KRISHNA GEETHA

入排标准

入选标准

  • 1\.Male and female patients aged 30 to 75 years
  • 2\.Patients with DPN based on their history and complaints were subjected to clinical examination and monofilament testing along with Michigan Neuropathy Screening Instrument (MNSI)
  • 3\.Patients with Type 2 DM with glycosylated hemoglobin \[HbA1c] ranging between 6\.5% and 10\.0%
  • 4\.Patients with painful DPN ranging from 1 month to 5 years.
  • 5\.Patients who provided informed consent

排除标准

  • 1\.Type 2 diabetes mellitus patients, diagnosed in past 1 year were excluded from the study
  • 2\.Patients with type 1 diabetes
  • 3\.Patients with any history of hypersensitivity reactions to pregabalin or nutraceuticals to be used in the study population.
  • 4\.Patients with hyperthyroidism, hypothyroidism, acromegaly, and Cushing’ syndrome
  • 5\.Patients with acute complications of Type 2 diabetes mellitus within the period of 6 months
  • 6\.Pregnant and lactating women

结局指标

主要结局

未指定

相似试验